In December, ZimVie announced its plans to sell its spine business to HIG Capital for $375 million. Now, the deal has been secured, and ZimVie is poised to be an exclusive dental implant company, according to a Feb. 28 news release. The sale is expected to be completed in the first half of 2024.
During the fourth quarter, ZimVie saw net sales of $113.1 million in the dental segment and $100.5 million in the spine segment — year-over-year decreases of 2.4% and 10.6%, respectively. Full year spine sales fell 9% year over year with $409.2 million, and full year dental sales fell 0.5% with $457.2 million.
